Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy
- 1 January 2007
- journal article
- case report
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 39 (4) , 347-350
- https://doi.org/10.1080/00365540600951341
Abstract
Neurological disease is the initial manifestation of acquired immunodeficiency syndrome (AIDS) in 10-20% of patients with HIV infection. Progressive multifocal leukoencephalopathy (PML) predominantly involves the cerebral hemispheres, with a small subset of patients having lesions predominantly or exclusively confined to the cerebellum. The radiological features of PML are typically non-inflammatory. As a result of potent antiretroviral therapy (ART), however, inflammatory lesions are becoming more common in HIV-infected individuals and are due, in part, to immune reconstitution that occurs in recipients of potent ART. In the majority of such cases, the clinical outcome of immune reconstitution PML has been beneficial to the host, although several case reports have described worsening or fatal outcomes in PML patients as a result of potent ART. The following 2 cases of immune reconstitution PML described in this report illustrate the varied radiological manifestations and clinical outcomes that can develop in AIDS patients with PML receiving potent ART. Moreover, these cases highlight the inflammatory changes observed on neuroimaging in AIDS patients with immune reconstitution PML receiving potent ART and to our knowledge are the first reports of immune reconstitution isolated to the cerebellum in such patients.Keywords
This publication has 18 references indexed in Scilit:
- Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathyActa Neuropathologica, 2005
- Fatal Immune Restoration Disease in Human Immunodeficiency Virus Type 1–Infected Patients with Progressive Multifocal Leukoencephalopathy: Impact of Antiretroviral Therapy–Associated Immune ReconstitutionClinical Infectious Diseases, 2002
- The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathyJournal of NeuroVirology, 2001
- Notes Progressive Multifocal Leukoencephalopathy in Patients with AIDS Receiving Highly Active Antiretroviral TherapyClinical Infectious Diseases, 1999
- Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDSAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Immune Recovery Vitritis Associated With Inactive Cytomegalovirus RetinitisArchives of Ophthalmology (1950), 1998
- Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 diseaseThe Lancet, 1998
- 2·5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapyThe Lancet, 1997
- Epidemiology of progressive multifocal leukoencephalopathy in the United StatesNeurology, 1991
- Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 1961